Rare Disease Report

Alnylam - A Rare Disease Company

JANUARY 07, 2017
Pushkal Garg, MD



Pushkal Garg, MD, of Alnylam Pharmaceuticals discusses what motivates their employees to develop orphan drugs for rare diseases - its the patients.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.